Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-15
2005-03-15
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
06867185
ABSTRACT:
The present invention relates to macrocyclic compounds, methods for making these compounds, pharmaceutical compositions and the therapeutic or prophylactic use of these compounds by administering said compounds to mammals or treat hepatitis C virus (HCV) infection.
REFERENCES:
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: WO 0059929 (2000-10-01), None
patent: WO 02060926 (2002-08-01), None
patent: WO 03064416 (2003-08-01), None
patent: WO 03064455 (2003-08-01), None
patent: WO 03064456 (2003-08-01), None
patent: WO 03066103 (2003-08-01), None
Campbell Jeffrey Allen
Good Andrew Charles
Audet Maury
Bristol--Myers Squibb Company
Leith Patricia
LandOfFree
Inhibitors of hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of hepatitis C virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419155